Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Shunyi Biotechnology is a life sciences company headquartered in Wuhan, China, specializing in the development and manufacture of high-quality biological reagents for research and diagnostic applications. The company offers an extensive catalog of products, including recombinant proteins, cytokines, growth factors, and a diverse range of monoclonal and polyclonal antibodies. Beyond its product portfolio, Wuhan Shunyi provides comprehensive contract research services, such as custom protein expression in mammalian, insect, and microbial systems, as well as antibody development and immunological assay services. Their products and services support a wide array of therapeutic areas, including oncology, immunology, and infectious diseases, serving academic institutions and pharmaceutical companies globally. The company is located in the Wuhan East Lake High-tech Development Zone, a major hub for biotechnology in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Shunyi Biotechnology.